Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Proof of Concept Study to Evaluate Administration of CN-105 in Patients With Acute Supratentorial Intracerebral Hemorrhage

Trial Profile

A Proof of Concept Study to Evaluate Administration of CN-105 in Patients With Acute Supratentorial Intracerebral Hemorrhage

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2018

At a glance

  • Drugs CN 105 (Primary)
  • Indications Cerebral haemorrhage
  • Focus Adverse reactions; Proof of concept
  • Acronyms CATCH
  • Sponsors AegisCN
  • Most Recent Events

    • 13 Dec 2018 Planned number of patients changed from 60 to 45.
    • 13 Dec 2018 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
    • 13 Dec 2018 Planned primary completion date changed from 1 Nov 2018 to 15 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top